Clinical Trial Update: A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating Paclitaxel, Carboplatin, and Megestrol acetate for uterine cancer; the study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Megestrol acetate (megestrol acetate)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Uterine Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-03-29